March 30, 2017 / 11:41 AM / 5 months ago

BRIEF-Rxi Pharmaceuticals reports Q4 loss per share $0.60

March 30 (Reuters) - Rxi Pharmaceuticals Corp

* Rxi Pharmaceuticals reports fourth quarter and year end 2016 financial results and recent corporate highlights

* Believes that its existing cash should be sufficient to fund operations for at least next twelve months

* Qtrly loss per share $0.60

* Rxi Pharmaceuticals Corp - research and development expense for quarter was $1.3 million compared with $1.7 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below